Press Release Cortexyme Announces Third Quarter 2019 Financial Results and Provides Business Update By admin | Press Release
EventsPress Release Cortexyme Announces Oral Presentation on COR388 at Clinical Trials on Alzheimer’s Disease 2019 By admin | Events, Press Release
EventsPress Release Cortexyme’s Approach to Addressing a Key Underlying Cause of Alzheimer’s Detailed at Alzheimer’s Association International Conference 2019 By admin | Events, Press Release
Press Release Cortexyme Expands Clinical Advisory Board With Key Clinical and Regulatory Experts By admin | Press Release
News Investor Business Daily – Why Alzheimer’s Treatment Hopes Endure Despite High-Profile Drug Failures By admin | News
EventsPress Release Cortexyme to Present at National Academies Forum on Tuesday, June 11, 2019 By admin | Events, Press Release
NewsPress Release Cortexyme Announces Phase 2/3 Clinical Trial Based on Transformational Understanding of Alzheimer’s Disease By admin | News, Press Release
NewsPress Release Cortexyme to Present Preclinical and Clinical Data Supporting its Novel Investigational Alzheimer’s Treatment at AD/PD 2019 By admin | News, Press Release
News New Scientist – We may finally know what causes Alzheimer’s – and how to stop it By admin | News
